Closure of Sde Avraham farm in Israel optimizes Company’s organizational structure by fully leveraging global import-export supply chain Increase in Revolving Credit Facility availability to $15 million supports increased...
IM Cannabis Reports Record Fourth Quarter and Fiscal Year 2021 Financial Results and Provides First Quarter 2022 Outlook Fiscal Year 2021 revenues increased 242% year-over-year to a record of...
Transaction expands IMC’s footprint into Israel’s largest city while positioning the Company as one of the largest retailers of medical cannabis in the country TORONTO, and GLIL YAM, Israel,...
IM Cannabis Closes Three Previously Announced Strategic Acquisitions in Israel All Requisite Approvals Received by Company to Complete Vironna, Pharm Yarok, and Panaxia Transactions TORONTO and GLIL YAM, Israel,...
IM Cannabis Reports Record Preliminary Fourth Quarter and Full Year 2021 Financial Results Q4 2021 revenues expected to be at least $20 million, an increase of at least 308%...
TORONTO, ON and GLIL YAM, Israel, Feb. 8, 2022 /PRNewswire/ — IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) (“IM Cannabis” or the “Company”), a leading medical and adult-use recreational...
IM Cannabis announces Focus Medical’s Import of 400 Kilograms of Premium-Indoor-Grown Dried Cannabis from Canada to Israel The successful import demonstrates the strength of the IM Cannabis global supply...
IM Cannabis Corp. Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company’s Israeli Subsidiary Oren Shuster remains Chief Executive Officer and Director of IM Cannabis...
IM Cannabis to Acquire Oranim, Jerusalem’s Leading Medical Cannabis Pharmacy Transaction positions IM Cannabis as one of the largest retailers of medical cannabis in Israel; Retail segment combined annualized...
IM Cannabis Announces Third Quarter 2021 Financial Results and Provides Outlook and Business Update Q3 2021 revenues of $14.4 million; a 30% increase from Q2 2021 Gross margin improved...
IM Cannabis Provides Update on German Operations and Financial Outlook TORONTO, ON, BAD OLDESLOE, GERMANY, and GLIL YAM, ISRAEL / ACCESSWIRE / July 23, 2021 / IM Cannabis Corp....
IMC subsidiary, Adjupharm, to expand German product portfolio with unique strains via supply agreements with The Green Organic Dutchman and Natural MedCo German Brand Institute awards IMC with the...
IM Cannabis Closes Acquisition of MYM Nutraceuticals TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / July 9, 2021 / IM Cannabis Corp. (“IMC” or the “Company”) (NASDAQ:IMCC)(CSE:IMCC), a...
IM Cannabis Announces Pricing of Proposed Public Offering of Securities TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / May 5, 2021 / IM Cannabis Corp. (“IMC” or the...
IM Cannabis to Acquire MYM Nutraceuticals and Its Licensed Producer Subsidiary, Highland Grow Highland Grow is currently profitable on an EBITDA basis and the Transaction is expected to be...
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / March 18, 2021 / IM Cannabis Corp. (the “Company” or “IMC”) (CSE:IMCC), (NASDAQ:IMCC), a multi-country operator (“MCO”) in the medical...
TORONTO, ON / ACCESSWIRE / March 18, 2021 / Trichome Financial Corp. (the “Company” or “Trichome Financial”) (CSE:TFC) is pleased to announce the closing of its previously announced combination with...
